Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference29 articles.
1. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer;Friede;Vaccine,2011
2. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic;Surichan;Vaccine,2011
3. FDA. Non-Inferiority Clinical Trials to Establish Effectiveness: Guidance for Industry. Available at: https://www.fda.gov/media/78504/download [accessed April 14].
4. FDA. Guidance for Industry: Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. Available at: https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Guidance-for-Industry--Clinical-Data-Needed-to-Support-the-Licensure-of-Seasonal-Inactivated-Influenza-Vaccines.pdf [accessed April 13].
5. WHO. WHO surveillance case definitions for ILI and SARI. Available at: https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari#:∼:text=SARI%20case%20definition,within%20the%20last%2010%20days.